GlobeNewswire Inc | Aug 5, 2020 04:01PM EDT

August 05, 2020

TUCSON, Ariz., Aug. 05, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the second quarter ended June 30, 2020 after the market close on Tuesday, August 11, 2020. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time.

Conference Call & Webcast Details Date: Tuesday, August 11Time: 4:30 pm Eastern TimeToll Free: 877-407-0789International: 201-689-8562Conference ID: 13706480Webcast: http://public.viavid.com/index.php?id= 140583

About HTGHTG is focused on NGS-based molecular profiling. The companys proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTGs customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Its mission is to empower precision medicine.

Contact: Ashley R. Robinson LifeSci Advisors, LLC Phone: (617) 430-7577 Email:arr@lifesciadvisors.com